Water T2 could predict functional decline in patients with dysferlinopathy.

Humans Water Muscular Dystrophies, Limb-Girdle / diagnosis Muscle, Skeletal / pathology Muscular Dystrophies / pathology
Limb girdle muscular dystrophy Limb girdle muscular dystrophy 2B Limb girdle muscular dystrophy R2 Magnetic resonance imaging Water T2

Journal

Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883

Informations de publication

Date de publication:
12 2022
Historique:
revised: 18 05 2022
received: 04 02 2022
accepted: 04 07 2022
pubmed: 5 9 2022
medline: 15 12 2022
entrez: 4 9 2022
Statut: ppublish

Résumé

Water T2 (T2 Patients with genetically confirmed dysferlinopathy were assessed as part of the Jain Foundation Clinical Outcomes Study in dysferlinopathy. The cohort included 18 patients from two sites, both equipped with 3-tesla magnetic resonance imaging (MRI) systems from the same vendor. T2 A higher T2 In dysferlinopathy, T2

Sections du résumé

BACKGROUND
Water T2 (T2
METHODS
Patients with genetically confirmed dysferlinopathy were assessed as part of the Jain Foundation Clinical Outcomes Study in dysferlinopathy. The cohort included 18 patients from two sites, both equipped with 3-tesla magnetic resonance imaging (MRI) systems from the same vendor. T2
RESULTS
A higher T2
CONCLUSIONS
In dysferlinopathy, T2

Identifiants

DOI: 10.1002/jcsm.13063 PMID: 36058852 PMC: PMC9745487
pubmed: 36058852
doi: 10.1002/jcsm.13063
pmc: PMC9745487
doi:

Substances chimiques

Water 059QF0KO0R

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

2888-2897

Informations de copyright

© 2022 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of Society on Sarcopenia, Cachexia and Wasting Disorders.

Références

J Cachexia Sarcopenia Muscle. 2022 Dec;13(6):2888-2897
pubmed: 36058852
Neurol Genet. 2016 Aug 04;2(4):e89
pubmed: 27602406
J Inherit Metab Dis. 2015 May;38(3):565-72
pubmed: 25749708
Neuromuscul Disord. 2014 May;24(5):390-2
pubmed: 24656605
Neurology. 2020 Apr 14;94(15):e1622-e1633
pubmed: 32184340
Sci Rep. 2018 Jul 18;8(1):10898
pubmed: 30022036
Magn Reson Med. 2013 Jul;70(1):155-9
pubmed: 22887356
Neurology. 2021 Aug 3;97(5):e513-e522
pubmed: 34162720
Dev Med Child Neurol. 2013 Nov;55(11):1046-52
pubmed: 23909763
Neurology. 2019 Jan 09;:
pubmed: 30626655
Acta Myol. 2020 Dec 01;39(4):179-186
pubmed: 33458572
Hum Mol Genet. 1994 Mar;3(3):455-7
pubmed: 8012357
Magn Reson Med. 2020 Nov;84(5):2656-2670
pubmed: 32306450
NMR Biomed. 2019 Aug;32(8):e4111
pubmed: 31180167
Muscle Nerve. 2018 Oct;58(4):550-558
pubmed: 30028523
J Neuroeng Rehabil. 2017 Sep 11;14(1):92
pubmed: 28893285
Lancet Neurol. 2016 Jan;15(1):65-77
pubmed: 26549782
Ann Neurol. 2021 May;89(5):967-978
pubmed: 33576057
Mol Neurobiol. 2018 Apr;55(4):2959-2966
pubmed: 28456937
Clin Genet. 2019 Oct;96(4):341-353
pubmed: 31268554
J Magn Reson Imaging. 2021 Jan;53(1):181-189
pubmed: 32761705
Sci Transl Med. 2015 Aug 5;7(299):299rv4
pubmed: 26246170
AJR Am J Roentgenol. 2004 Aug;183(2):343-51
pubmed: 15269023
Neuropathol Appl Neurobiol. 2002 Dec;28(6):461-70
pubmed: 12445162
Neurology. 1989 Apr;39(4):475-81
pubmed: 2927672
J Neurol Neurosurg Psychiatry. 2018 Oct;89(10):1071-1081
pubmed: 29735511
Curr Opin Neurol. 2020 Oct;33(5):611-620
pubmed: 32796278
Neuromuscul Disord. 2021 Apr;31(4):265-280
pubmed: 33610434
J Magn Reson Imaging. 2015 Mar;41(3):645-53
pubmed: 24590466
NMR Biomed. 2017 Jan;30(1):
pubmed: 27859827
Neurol Res. 2010 Feb;32(1):41-6
pubmed: 20092694
J Neuromuscul Dis. 2020;7(4):495-504
pubmed: 32925090
Neurology. 2014 Sep 9;83(11):974-80
pubmed: 25098537
J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1850-1863
pubmed: 35373496
Ann Neurol. 2020 Oct;88(4):669-681
pubmed: 32495452
Neurology. 2020 Mar 3;94(9):e897-e909
pubmed: 32024675
Gait Posture. 2013 Jun;38(2):270-5
pubmed: 23273489
J Neuromuscul Dis. 2016 Mar 3;3(1):1-28
pubmed: 27854210
J Bras Pneumol. 2018 Apr;44(2):84
pubmed: 29791550
J Neurol. 2017 Oct;264(10):2053-2067
pubmed: 28669118
Neurology. 2017 Nov 14;89(20):2057-2065
pubmed: 29030457
Brain. 1986 Feb;109 ( Pt 1):31-54
pubmed: 3942856

Auteurs

Ursula Moore (U)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Ericky Caldas de Almeida Araújo (E)

NMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
NMR Laboratory, CEA/DRF/IBFJ/MIRCen, Paris, France.

Harmen Reyngoudt (H)

NMR Laboratory, Neuromuscular Investigation Center, Institute of Myology, Paris, France.
NMR Laboratory, CEA/DRF/IBFJ/MIRCen, Paris, France.

Heather Gordish-Dressman (H)

Center for Translational Science, Division of Biostatistics and Study Methodology, Children's National Health System, Washington, DC, USA.
Pediatrics, Epidemiology and Biostatistics, George Washington University, Washington, DC, USA.

Fiona E Smith (FE)

Magnetic Resonance Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Ian Wilson (I)

Magnetic Resonance Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Meredith James (M)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Anna Mayhew (A)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Laura Rufibach (L)

Jain Foundation, Seattle, WA, USA.

John W Day (JW)

Department of Neurology and Neurological Sciences, Stanford University School of Medicine, Stanford, CA, USA.

Kristi J Jones (KJ)

The Children's Hospital at Westmead and The University of Sydney, Sydney, NSW, Australia.

Diana X Bharucha-Goebel (DX)

Department of Neurology, Children's National Health System, Washington, DC, USA.
National Institutes of Health (NINDS), Bethesda, MD, USA.

Emmanuelle Salort-Campana (E)

Service des maladies neuromusculaire et de la SLA, Hôpital de La Timone, Marseille, France.

Alan Pestronk (A)

Department of Neurology, Washington University School of Medicine, St. Louis, MO, USA.

Maggie C Walter (MC)

Friedrich-Baur-Institute, Department of Neurology, Ludwig-Maximilians-University of Munich, Munich, Germany.

Carmen Paradas (C)

Neuromuscular Unit, Department of Neurology, Hospital U. Virgen del Rocío/Instituto de Biomedicina de Sevilla, Sevilla, Spain.

Tanya Stojkovic (T)

Centre de référence des maladies neuromusculaires, Institut de Myologie, AP-HP, Sorbonne Université, Hôpital Pitié-Salpêtrière, Paris, France.

Madoka Mori-Yoshimura (M)

Department of Neurology, National Center Hospital, National Center of Neurology and Psychiatry, Tokyo, Japan.

Elena Bravver (E)

Neuroscience Institute, Carolinas Neuromuscular/ALS-MDA Center, Carolinas HealthCare System, Charlotte, NC, USA.

Elena Pegoraro (E)

Department of Neuroscience, University of Padova, Padua, Italy.

Jerry R Mendell (JR)

The Abigail Wexner Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.

Kate Bushby (K)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Andrew M Blamire (AM)

Magnetic Resonance Centre, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.

Volker Straub (V)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.

Pierre G Carlier (PG)

Université Paris-Saclay, CEA, DRF, Service Hospitalier Frederic Joliot, Orsay, France.

Jordi Diaz-Manera (J)

The John Walton Muscular Dystrophy Research Centre, Translational and Clinical Research Institute, Newcastle University and Newcastle Hospitals NHS Foundation Trust, Newcastle upon Tyne, UK.
Neuromuscular Disorders Unit, Neurology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
Centro de Investigación Biomédica en Red en Enfermedades Raras (CIBERER), Madrid, Spain.
ORCID: 0000-0003-2941-7988

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Water T2 could predict functional decline in...
questionsmedicales.fr › Produits chimiques inorganiques › Composés de l'oxygène › Oxydes › Eau › Water T2 could predict functional decline in...
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Dystrophies musculaires › Dystrophies musculaires des ceintures › Water T2 could predict functional decline in...
questionsmedicales.fr › Tissus › Muscles › Muscle strié › Muscles squelettiques › Water T2 could predict functional decline in...
questionsmedicales.fr › Malformations et maladies congénitales, héréditaires et néonatales › Maladies génétiques congénitales › Dystrophies musculaires › Water T2 could predict functional decline in...